News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
San Antonio, Texas-based StemBioSys has closed an $8m round of Series A preferred stock financing that it will use to help launch its bone marrow-High Performance MicroEnvironment (BM-HPME) stem cell culture system.
Dispatches from NIBRT
Ireland is trying to compete in biomanufacturing with powerhouses like Puerto Rico and Singapore thanks to government-financed innovation in process development.
Sartorius has expanded its biopharma services to include contract testing by buying CRO BioOutsource.
Dispatches from BPI Europe
With an internal diameter of 60cm, Repligen says its pre-packed disposable column will cater for future downstream demands.